Clinical Trial Update: Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating total neoadjuvant therapy with Fianlimab and Cemiplimab for melanoma; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Cemiplimab (cemiplimab)
• Fianlimab (fianlimab)

Snippet

Sponsor: University of California, Irvine | Conditions: Melanoma (Skin) | Phase 2 | Status: NOT_YET_RECRUITING